If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,155.00    15.00 (0.29%)
Bid:
5,150.00
Ask:
5,160.00
Spread: 10.00 (0.194%)
Market Cap: £18.79b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

23 Dec 2025 14:45

RNS Number : 7108M
Coca-Cola HBC AG
23 December 2025
 

FOR IMMEDIATE RELEASE

23 December 2025

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company notifies that the following PDMR has been granted at nil cost performance shares of CHF 6.70 each ("Shares") in the Company on 10 November 2025 through her participation in the Stock Option and Performance Share Award Plan ("PSP"). The performance shares will vest as described below subject to achievement of performance conditions.

 PDMR

Number of Shares granted under the PSP

Share price

PANAGIOTA KALOGERAKI

5,898.31

GBP 35.90

 

The Notification of Dealing Forms for each PDMR can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

PANAGIOTA KALOGERAKI

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF OPERATING OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

SHARES

 

 

CH0198251305

b)

 

Nature of the transaction

 

 

GRANTING OF PERFORMANCE SHARES AT NIL COST WHICH WILL VEST IN NOVEMBER 2028 SUBJECT TO ACHIEVEMENT OF PERFORMANCE CONDITIONS OF THE 2025-2027 PERFORMANCE SHARE PLAN.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

35.90 GBP

5,898.31

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

35.90 GBP

5,898.31

211,749.329 GBP

e)

 

Date of the transaction

 

2025-11-10

f)

 

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation. The grant of the Shares was deferred for administrative reasons and to ensure compliance with the Market Abuse Regulation while the recipient was in possession of inside information.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKNBDQBDDCBB
Date   Source Headline
3rd Apr 201810:31 amRNSIssue of equity and total voting rights
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.